Literature DB >> 2202139

Cholecystokinin and anxiety.

S Ravard1, C T Dourish.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2202139     DOI： 10.1016/0165-6147(90)90004-r

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  19 in total

1.  Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory.

Authors:  J Shepherd; D J Bill; C T Dourish; S S Grewal; A McLenachan; K J Stanhope
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

2.  CCK-A and CCK-B selective receptor agonists and antagonists modulate olfactory recognition in male rats.

Authors:  M Lemaire; G A Böhme; O Piot; B P Roques; J C Blanchard
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

3.  Inter- and intraspecies polymorphisms in the cholecystokinin-B/gastrin receptor alter drug efficacy.

Authors:  A S Kopin; E W McBride; M C Gordon; S M Quinn; M Beinborn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effects.

Authors:  M B Assié; P Chopin; A Stenger; C Palmier; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  The benzodiazepine antagonist flumazenil blocks the effects of CCK receptor agonists and antagonists in the elevated plus-maze.

Authors:  P Chopin; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-maze.

Authors:  E Vasar; E Peuranen; T Oöpik; J Harro; P T Männistö
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Effects of the CCKB antagonist L-365, 260 on benzodiazepine withdrawal-induced hypophagia in rats.

Authors:  A J Goudie; M J Leathley
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

8.  Cholecystokinin release mediated by 5-HT3 receptors in rat cerebral cortex and nucleus accumbens.

Authors:  P Paudice; M Raiteri
Journal:  Br J Pharmacol       Date:  1991-07       Impact factor: 8.739

9.  Social isolation of rats increases the density of cholecystokinin receptors in the frontal cortex and abolishes the anti-exploratory effect of caerulein.

Authors:  E Vasar; E Peuranen; J Harro; A Lang; L Oreland; P T Männistö
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

10.  Inhibition by 5-HT3 receptor antagonists of release of cholecystokinin-like immunoreactivity from the frontal cortex of freely moving rats.

Authors:  M Raiteri; P Paudice; F Vallebuona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-01       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.